{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:35:35Z","timestamp":1770136535371,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Giuseppina Ciccarelli"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.neulet.2017.06.032","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T04:31:00Z","timestamp":1498019460000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Disruption of GABA(A)-mediated intracortical inhibition in patients with chorea-acanthocytosis"],"prefix":"10.1016","volume":"654","author":[{"given":"Raffaele","family":"Dubbioso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiore","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.06.032_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14802\/jmd.15009","article-title":"Untangling the thorns: advances in the neuroacanthocytosis syndromes","volume":"8","author":"Walker","year":"2015","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neulet.2017.06.032_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2013.10.011","article-title":"Chorein, the protein responsible for chorea-acanthocytosis, interacts with \u03b2-adducin and \u03b2-actin","volume":"441","author":"Shiokawa","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2017.06.032_bib0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-013-1241-3","article-title":"Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures","volume":"127","author":"Connolly","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbrc.2006.10.070","article-title":"Chorein deficiency leads to upregulation of gephyrin and GABAA receptor","volume":"351","author":"Kurano","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2017.06.032_bib0025","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.clinph.2014.08.028","article-title":"TMS and drugs revisited 2014","volume":"126","author":"Ziemann","year":"2015","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.clinph.2010.10.025","article-title":"Electrophysiological characterisation in hereditary spastic paraplegia type 5","volume":"122","author":"Manganelli","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jns.2014.12.005","article-title":"Electrophysiological characterization of adult-onset Niemann-Pick type C disease","volume":"348","author":"Iodice","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2017.06.032_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2016.01.024","article-title":"Subclinical neurological involvement does not develop if Wilson\u2019s disease is treated early","volume":"24","author":"Dubbioso","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2017.06.032_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1113\/jphysiol.2005.092155","article-title":"Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition","volume":"569","author":"Di Lazzaro","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1113\/jphysiol.2004.061747","article-title":"Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans","volume":"564","author":"Di Lazzaro","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/cercor\/bhm100","article-title":"Intracortical hyperexcitability in humans with a GABAA receptor mutation","volume":"18","author":"Fedi","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neulet.2017.06.032_bib0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00228633","article-title":"The effect of Iorazepam on the motor cortical excitability in man","volume":"109","author":"Ziemann","year":"1996","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neulet.2017.06.032_bib0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2016.02.077","article-title":"Phenotypic abnormalities in a chorea-acanthocytosis mouse model are modulated by strain background","volume":"472","author":"Sakimoto","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2017.06.032_bib0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2015.09.030","article-title":"Cortical inhibitory deficits in premanifest and early Huntington\u2019s disease","volume":"296","author":"Philpott","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2017.06.032_bib0075","first-page":"131","article-title":"Cortical excitability and neurology: insights into the pathophysiology","volume":"27","author":"Badawy","year":"2012","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00415-014-7282-2","article-title":"Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer\u2019s disease?","volume":"261","author":"Manganelli","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2017.06.032_bib0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00702-015-1428-y","article-title":"Short-latency afferent inhibition in patients with Parkinson\u2019s disease and freezing of gait","volume":"122","author":"Picillo","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2017.06.032_bib0090","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.brs.2015.05.012","article-title":"The effect of cerebellar degeneration on human sensori-motor plasticity","volume":"8","author":"Dubbioso","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.neulet.2017.06.032_bib0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/01.wnl.0000204183.26231.23","article-title":"In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias","volume":"66","author":"Di Lazzaro","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2017.06.032_bib0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1523\/JNEUROSCI.20-01-00066.2000","article-title":"Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks","volume":"20","author":"Alkondon","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.06.032_bib0105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neubiorev.2011.01.001","article-title":"The neuropsychiatry of neuroacanthocytosis syndromes","volume":"35","author":"Walterfang","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2017.06.032_bib0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.biopsych.2008.12.026","article-title":"Abnormal motor cortex excitability in preclinical and very early Huntington\u2019s disease","volume":"65","author":"Schippling","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2017.06.032_bib0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.neuropharm.2006.02.002","article-title":"Seeking a mechanism of action for the novel anticonvulsant lacosamide","volume":"50","author":"Errington","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2017.06.032_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eplepsyres.2004.08.001","article-title":"Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function\u2014a TMS study","volume":"62","author":"Reis","year":"2004","journal-title":"Epilepsy Res."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017305128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017305128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T08:33:02Z","timestamp":1569486782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017305128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"alternative-id":["S0304394017305128"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.06.032","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of GABA(A)-mediated intracortical inhibition in patients with chorea-acanthocytosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}